HEALTH

NEW YORK Cases of the potentially deadly skin cancer melanoma are expected to almost double before the end of the decade, according to a new report by research firm Datamonitor.

Research by the company indicated that cases of melanoma could go from the 138,000 new cases expected this year to 227,000 by 2019.

INDIANAPOLIS The nation's largest retailer has teamed up with a drug company to provide an affordable insulin option for people with diabetes.

Lilly's Humulin will be offered by mid-September to Walmart pharmacy patients under the dual-branded name Humulin ReliOn, including 10 mL vials of Humulin R U-100, Humulin N and Humulin 70/30 formulations.